Multicenter trial L-carnitine maintenance hemodialysis patients Carnitine concentrations lipid effects Previous studies conflicting results carnitine supplementation plasma lipids patients chronic renal failure center double-blind placebo trial effects post-hemodialysis intravenous injection L-carnitine ESRD patients maintenance hemodialysis Thirty-eight patients months L-carnitine infusions mg/kg post-dialysis patients placebo infusions groups patients baseline pre-dialysis plasma red blood cell total carnitine levels normal pre-dialysis plasma-free carnitine concentrations free/total ratios subnormal acyl levels Post-dialysis plasma free total carnitine concentrations subnormal Plasma red blood cell total carnitine levels carnitine recipients unchanged baseline placebo significant changes plasma triglycerides HDL-cholesterol lipoprotein parameters carnitine placebo groups carnitine metabolism uremia Furthermore randomly-selected hemodialysis population L-carnitine injection dose mg/kg results significant increases blood tissue carnitine levels major effects lipid profiles 